Clinical Trials Directory

Trials / Unknown

UnknownNCT02143505

Study of Calcium Plus Vitamin D Supplementation in Prevention of Colorectal Adenomas Recurrence

Calcium Plus Vitamin D Supplementation in Prevention of Colorectal Adenomas Recurrence:a Prospective, Randomized, Placebo-controlled, Multicenter Clinical Trial

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
900 (estimated)
Sponsor
Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Calcium plus vitamin D may be effective in the prevention of colorectal adenoma recurrence. The aim of this study is to investigate the effect of supplementation with calcium plus vitamin D on the recurrence of colorectal adenomas.

Detailed description

Colorectal adenomas are well-known to be precancerous lesions that develop into colorectal cancers on the basis of the adenoma-carcinoma sequence. The effects of screening for colorectal adenomas and removing precancerous lesions on the prevention of colorectal cancer have been established. Because of the high recurrence rates of colorectal adenomas in patients who have undergone polypectomy, the potential chemopreventive agents that may reduce the risk of colorectal adenoma recurrence need to be investigated. Since laboratory and epidemiologic evidence suggests that calcium or vitamin D may help prevent colorectal adenomas, we conduct a randomized, placebo-controlled, prospective clinical trial to study the effect and safety of calcium plus vitamin D supplementation in prevention of colorectal adenomas recurrence.

Conditions

Interventions

TypeNameDescription
DRUGCa plus vit Delemental calcium 1200mg/d plus vitamin D3 250 IU/d daily supplements

Timeline

Start date
2014-03-01
Primary completion
2017-02-01
Completion
2019-02-01
First posted
2014-05-21
Last updated
2014-05-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02143505. Inclusion in this directory is not an endorsement.